Clinical trial

Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease

NCT00304629

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-03-01

PhasePHASE3

Study timeline

Study start (unknown)2000-03-01Date precision: month

Registry last updated2011-02-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

galantamineDRUG · verified · RxNorm: galantamine

Sponsors & collaborators

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00304629 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.